Das Sarkoid als häufigster Hauttumor bei Pferden und Pferdeartigen

Das Sarkoid ist mit einer Prävalenz von 1–12 % der häufigste Hauttumor bei Pferdeartigen; also Pferden, Eseln, Maultieren, Mauleseln und Zebras. Sowohl bei seiner Induktion als auch bei der Progression spielen Traumen eine entscheidende Rolle. Ist die korrekte Diagnose gestellt, sollte bei allen Sarkoiden eine wirksame, individuell angepasste Therapie durchgeführt werden.

• Literatur

• 1 Ashrafi GH, Piuko K, Burden F, Yuan Z, Gault EA, Müller M, Trawford A, Reid SW, Nasir L, Campo MS. Vaccination of sarcoid-bearing donkeys with chimeric virus-like particles of bovine papillomavirus type 1. J Gen Virol 2008; 89 (1) 148-157
• 2 Bergvall KE. Sarcoids. Vet Clin North Am Equine Pract 2013; 29 (3) 657-671
• 3 Bogaert L, Martens A, Van Poucke M, Ducatelle R, De Cock H, Dewulf J, De Baere C, Peelman L, Gasthuys F. High prevalence of bovine papillomaviral DNA in the normal skin of equine sarcoid-affected and healthy horses. Vet Microbiol 2008; 129(1–2): 58-68
• 4 Broström H, Fahlbrink E, Dubath ML, Lazary S. Association between equine leucocyte antigens (ELA) and equine sarcoid tumors in the population of Swedish halfbreds and some of their families. Vet Immunol Immunopathol 1988; 19(3–4): 215-223
• 5 Campo MS. Papillomavirus Research. Caister Academic Press; 2006
• 6 Carr EA, Théon AP, Madewell BR, Griffey SM, Hitchcock ME. Bovine papillomavirus DNA in neoplastic and nonneoplastic tissues obtained from horses with and without sarcoids in the western United States. Am J Vet Res 2001; 62 (5) 741-744
• 7 Chambers G, Ellsmore VA, OʼBrien PM, Reid SW, Love S, Campo MS, Nasir L. Association of bovine papillomavirus with the equine sarcoid. J Gen Virol 2003; 84 (5) 1055-1062
• 8 Espy BM. How to treat equine sarcoids by autologous implantation. AAEP Proceedings 2008; 54: 68-73
• 9 Hainisch EK, Abel H, Shafti-Keramat S, Kirnbauer R, Brandt S. BPV-1 L1 VLP Vaccination protects horses from experimental BPV-1 Infection. 28th International Papillomavirus Conference; Nov 30 – Dec 6, 2012; San Juan, Puerto Rico.
• 10 Hainisch EK, Brandt S, Shafti-Keramat S, Van den Hoven R, Kirnbauer R. Safety and immunogenicity of BPV-1 L1 virus-like particles in a dose-escalation vaccination trial in horses. Equine Vet J 2012; 44 (1) 107-111
• 11 Hallamaa RE, Saario E, Tallberg T. Macroscopical and histopathological changes in regressing primary and recurrent equine sarcoids during active specific bio-immunotherapy. In vivo (Athens, Greece) 2005; 19 (4) 761-767
• 12 Hewes CA, Sullins KE. Use of cisplatin-containing biodegradable beads for treatment of cutaneous neoplasia in equidae: 59 cases (2000–2004). J Am Vet Med Assoc 2006; 229 (10) 1617-1622
• 13 Kemp-Symonds JG, Nixon JVM. Carbon Dioxide Laser Surgery as a Treatment for Equine Sarcoid: Outcome and Complications in 24 Patients. Proceedings of the BEVA Congress, 2008: 251.
• 14 Kirnbauer R. Papillomavirus-like particles for serology and vaccine development. Intervirology 1996; 39(1–2): 54-61
• 15 Klein WR, Bras GE, Misdorp W, Steerenberg PA, de Jong WH, Tiesjema RH, Kersjes AW, Ruitenberg EJ. Equine sarcoid: BCG immunotherapy compared to cryosurgery in a prospective randomised clinical trial. Cancer Immunol Immunother 1986; 21 (2) 133-140
• 16 Knottenbelt DC, Kelly DF. The diagnosis and treatment of periorbital sarcoid in the horse: 445 cases from 1974 to 1999. Vet ophthalmol 2000; 3(2–3): 169-191
• 17 Mattil-Fritz S, Scharner D, Piuko K, Thönes N, Gissmann L, Müller H, Müller M. Immunotherapy of equine sarcoid: dose-escalation trial for the use of chimeric papillomavirus-like particles. G Gen Virol 2008; 89(Pt 1): 138-147
• 18 Nasir L, Brandt S. Papillomavirus associated diseases of the horse. Vet Microbiol 2013; 167(1–2): 159-167
• 19 Nasir L, Campo MS. Bovine papillomaviruses: their role in the aetiology of cutaneous tumours of bovids and equids. Vet Dermatol 2008; 19 (5) 243-254
• 20 Nasir L, Reid SW. Bovine papillomaviruses and equine sarcoids. In: M.S. CAMPO, ed. Papillomavirus Research. From natural history to vaccines and beyond. Norfolk: Caister Academic Press; 2006: 389-397
• 21 Nogueira SA, Torres SM, Malone ED, Diaz SF, Jessen C, Gilbert S. Efficacy of imiquimod 5 % cream in the treatment of equine sarcoids: A pilot study. Vet Dermatol 2006; 17 (4) 259-265
• 22 Pascoe RR, Knottenbelt DC. Manual of Equine Dermatology. Philadelphia: Saunders; 1999
• 23 Pilsworth RC, Knottenbelt DC. Equine Sarcoid. Eq Vet Educ 2007; 19: 260-262
• 24 Rooney JR, Robertson JL. Equine Pathology. Ames: Iowa State University Press; 1996
• 25 Scott DW, Miller WHJ. Equine Dermatology. St. Louis: Saunders; 2003
• 26 Stadler S, Kainzbauer C, Haralambus R, Brehm W, Hainisch E, Brandt S. Successful treatment of equine sarcoids by topical aciclovir application. Vet Rec 2011; 168 (7) 187
• 27 Théon AP, Wilson WD, Magdesian KG, Pusterla N, Snyder JR, Galuppo LD. Long-term outcome associated with intratumoral chemotherapy with cisplatin for cutaneous tumors in equidae: 573 cases (1995–2004). J Am Vet Med Assoc 2007; 230 (10) 1506-1513
• 28 Villa LL, Costa RL, Petta CA, Andrade RP, Ault KA, Giuliano AR, Wheeler CM, Koutsky LA, Malm C, Lehtinen M, Skjeldestad FE, Olsson SE, Steinwall M, Brown DR, Kurman RJ, Ronnett BM, Stoler MH, Ferenczy A, Harper DM, Tamms GM, Yu J, Lupinacci L, Railkar R, Taddeo FJ, Jansen KU, Esser MT, Sings HL, Saah AJ, Barr E. Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial. Lancet Oncol 2005; 6 (5) 271-278